📊 CVRX Key Takeaways
Is CVRx, Inc. (CVRX) a Good Investment?
CVRx exhibits severe operational losses despite strong gross margins, indicating fundamental business model challenges beyond cost of goods sold. The company is heavily cash-dependent with negative free cash flow of -$40.8M and operating losses of -$51.3M, creating a runway concern even with substantial cash reserves of $75.7M. Revenue growth of 10.4% YoY is insufficient to justify the magnitude of operating losses and negative unit economics.
CVRx shows a strong gross margin profile and double-digit revenue growth, which suggests the core product economics are attractive. However, those positives are overwhelmed by extremely weak operating leverage, with operating and net losses near revenue scale, deeply negative free cash flow, and poor returns on capital. The balance sheet still has meaningful cash, but the current burn rate and leverage leave limited room for execution missteps unless revenue growth accelerates materially and losses narrow.
Why Buy CVRx, Inc. Stock? CVRX Key Strengths
- Exceptional gross margin of 85.3% demonstrates strong pricing power and product-market fit at the manufacturing level
- Robust cash position of $75.7M provides runway to reach profitability, reducing near-term liquidity risk
- Double-digit revenue growth of 10.4% YoY shows market adoption and demand for core products
- High gross margin of 85.3% indicates favorable unit economics and pricing power
- Revenue grew 10.4% year over year, showing ongoing commercial adoption
- Strong liquidity ratios and $75.71M of cash provide near-term operating flexibility
CVRX Stock Risks: CVRx, Inc. Investment Risks
- Severe operating losses of -$51.3M with -90.5% operating margin indicate substantial costs in R&D, SG&A, or operations that are not scaling with revenue
- Negative free cash flow of -$40.8M at current revenue levels means the business consumes cash even with positive gross profit, questioning path to sustainability
- Cash burn rate of approximately -$40M+ annually combined with $49.5M long-term debt load suggests 1.5-2 year runway before cash depletion absent profitability inflection
- Operating margin of -90.5% and net margin of -94.1% show the business remains far from self-sustaining
- Free cash flow of -$40.75M versus $75.71M cash implies a short runway if burn does not improve
- Debt/equity of 1.26x and negative interest coverage indicate meaningful balance-sheet and financing risk
Key Metrics to Watch
- Path to operating profitability and timeline to positive operating income
- Operating expense rationalization as a percentage of revenue
- Cash burn rate trend and months of runway remaining
- Gross profit dollar growth relative to operating loss reduction
- Revenue growth relative to operating expense growth
- Quarterly free cash flow burn and ending cash balance
CVRx, Inc. (CVRX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 7.63x current ratio provides a solid financial cushion.
CVRX Profit Margin, ROE & Profitability Analysis
CVRX vs Healthcare Sector: How CVRx, Inc. Compares
How CVRx, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is CVRx, Inc. Stock Overvalued? CVRX Valuation Analysis 2026
Based on fundamental analysis, CVRx, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
CVRx, Inc. Balance Sheet: CVRX Debt, Cash & Liquidity
CVRX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: CVRx, Inc.'s revenue has grown significantly by 335% over the 5-year period, indicating strong business expansion. The most recent EPS of $-2.65 indicates the company is currently unprofitable.
CVRX Revenue Growth, EPS Growth & YoY Performance
CVRX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $13.4M | -$12.9M | $-0.49 |
| Q2 2025 | $11.8M | -$14.0M | $-0.57 |
| Q1 2025 | $10.8M | -$13.8M | $-0.53 |
| Q3 2024 | $10.5M | -$9.0M | $-0.43 |
| Q2 2024 | $9.5M | -$11.7M | $-0.56 |
| Q1 2024 | $8.0M | -$11.4M | $-0.55 |
| Q3 2023 | $6.2M | -$9.0M | $-0.43 |
| Q2 2023 | $5.0M | -$11.1M | $-0.54 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CVRx, Inc. Dividends, Buybacks & Capital Allocation
CVRX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for CVRx, Inc. (CIK: 0001235912)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Apr 13, 2026 | 8-K | tm2611335d1_8k.htm | View → |
| Mar 16, 2026 | 4 | xslF345X05/form4-03162026_080309.xml | View → |
| Mar 4, 2026 | 4 | xslF345X05/form4-03042026_090343.xml | View → |
| Mar 3, 2026 | 4 | xslF345X05/form4-03032026_110335.xml | View → |
| Mar 3, 2026 | 4 | xslF345X05/form4-03032026_110358.xml | View → |
❓ Frequently Asked Questions about CVRX
What is the AI rating for CVRX?
CVRx, Inc. (CVRX) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 85% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CVRX's key strengths?
Claude: Exceptional gross margin of 85.3% demonstrates strong pricing power and product-market fit at the manufacturing level. Robust cash position of $75.7M provides runway to reach profitability, reducing near-term liquidity risk. ChatGPT: High gross margin of 85.3% indicates favorable unit economics and pricing power. Revenue grew 10.4% year over year, showing ongoing commercial adoption.
What are the risks of investing in CVRX?
Claude: Severe operating losses of -$51.3M with -90.5% operating margin indicate substantial costs in R&D, SG&A, or operations that are not scaling with revenue. Negative free cash flow of -$40.8M at current revenue levels means the business consumes cash even with positive gross profit, questioning path to sustainability. ChatGPT: Operating margin of -90.5% and net margin of -94.1% show the business remains far from self-sustaining. Free cash flow of -$40.75M versus $75.71M cash implies a short runway if burn does not improve.
What is CVRX's revenue and growth?
CVRx, Inc. reported revenue of $56.7M.
Does CVRX pay dividends?
CVRx, Inc. does not currently pay dividends.
Where can I find CVRX SEC filings?
Official SEC filings for CVRx, Inc. (CIK: 0001235912) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CVRX's EPS?
CVRx, Inc. has a diluted EPS of $-2.04.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CVRX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, CVRx, Inc. has a SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CVRX stock overvalued or undervalued?
Valuation metrics for CVRX: ROE of -135.6% (sector avg: 15%), net margin of -94.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy CVRX stock in 2026?
Our dual AI analysis gives CVRx, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CVRX's free cash flow?
CVRx, Inc.'s operating cash flow is $-40.2M, with capital expenditures of $580.0K. FCF margin is -71.9%.
How does CVRX compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -94.1% (avg: 12%), ROE -135.6% (avg: 15%), current ratio 7.63 (avg: 2).